MEDIFAST (MED)
(Delayed Data from NYSE)
$18.44 USD
+0.16 (0.88%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $18.46 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.44 USD
+0.16 (0.88%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $18.46 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
Clorox (CLX) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Elevated manufacturing and logistics costs might have hurt Clorox's (CLX) bottom line in fourth-quarter fiscal 2021. Nonetheless, its IGNITE strategy and cost-saving initiatives are encouraging.
Freshpet (FRPT) to Post Q2 Earnings: What Awaits the Stock?
by Zacks Equity Research
Freshpet's (FRPT) second-quarter performance is likely to have gained from strong consumption trends. However, rising freight and beef costs are a concern.
Have Faith in DuPont Analysis: Buy 5 Top-Ranked Stocks
by Sanghamitra Saha
DuPont technique helps investors to analyze basic ROE at an advanced level. Bet on these five stocks.
Why Medifast (MED) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Medifast (MED) have what it takes? Let's find out.
Lamb Weston (LW) Q4 Earnings & Sales Top Estimates, Rise Y/Y
by Zacks Equity Research
Lamb Weston's (LW) fourth-quarter fiscal 2021 results reflect higher earnings and sales. Management expects continued demand recovery, though cost inflation and disrupted supply chain are concerning.
Factors Setting the Tone for Procter & Gamble's (PG) Q4 Earnings
by Zacks Equity Research
Although cost and currency woes remain concerns, Procter & Gamble's (PG) Q4 results are likely to have gained from continued demand for cleaning products as well as productivity and cost-saving plans.
Things You Need to Know Before Colgate's (CL) Q2 Earnings
by Zacks Equity Research
Strong demand, robust pricing, productivity gains and digital growth are likely to have aided Colgate (CL) in Q2. Elevated advertising, logistics and raw-material expenses remain concerns.
Hershey (HSY) Gears Up to Report Q2 Earnings: What to Expect
by Zacks Equity Research
Hershey's (HSY) second-quarter 2021 results are likely to reflect a rebound in the away-from-home business on higher consumer mobility. However, higher advertising expense may have been a concern.
Church & Dwight (CHD) Queued for Q2 Earnings: Things to Note
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter 2021 results are likely to reflect solid demand for household and personal care products, though escalated costs have been a concern.
Altria (MO) Lined Up for Q2 Earnings: Key Things to Note
by Zacks Equity Research
Altria's (MO) second-quarter 2021 results are likely to reflect solid pricing power and strength in oral tobacco products.
Factors Likely to Influence Keurig Dr Pepper's (KDP) Q2 Earnings
by Zacks Equity Research
Improved at-home penetration and market share gains across the portfolio are likely to have aided Keurig Dr Pepper (KDP) in Q2. Headwinds in the away-from-home channel and currency woes are concerns.
Know How AB InBev (BUD) is Positioned Ahead of Q2 Earnings
by Zacks Equity Research
AB InBev (BUD) is expected to have gained from strength in premium brands, e-commerce and its unique commercial strategy in Q2. Cost headwinds are likely to have hurt.
Molson Coors (TAP) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Revitalization plan, premiumization, beyond beer expansion and omni-channel investment are likely to have aided Molson Coors (TAP) in Q2. Higher marketing spends and COGS are likely to have hurt.
Kimberly-Clark (KMB) Cuts 2021 View on Q2 Earnings & Sales Miss
by Zacks Equity Research
Kimberly-Clark's (KMB) second-quarter 2021 results reflect lower earnings due to increased input costs. Management cuts 2021 view for sales, earnings and adjusted operating profit.
Lamb Weston (LW) Expands French Fry Capacity to Fuel Growth
by Zacks Equity Research
Lamb Weston (LW) is expanding french fry processing capacity at its existing American Falls, ID facility. Management declares quarterly dividend.
Pilgrim's Pride (PPC) Queued for Q2 Earnings: Things to Note
by Zacks Equity Research
Pilgrim's Pride's (PPC) second-quarter 2021 results are likely to reflect gains from U.S. foodservice recovery and higher online sales, though escalated costs are concerning.
4 Reasons Why The J.M. Smucker (SJM) Stock Appears Promising
by Zacks Equity Research
The J.M. Smucker (SJM) is benefiting from its prudent pricing efforts, brand strength and solid digital sales. The company's shareholder-friendly moves are also worth noting.
Service Corporation (SCI) Queued for Q2 Earnings: Things to Note
by Zacks Equity Research
Service Corporation's (SCI) second-quarter results are likely to reflect higher revenues from pandemic-led increased burials and funeral services performed, along with gains from solid cost control.
Mondelez (MDLZ) to Report Q2 Earnings: What Should You Expect?
by Zacks Equity Research
Mondelez's (MDLZ) second-quarter 2021 performance is likely to reflect gains from continued demand for snacks and prudent buyouts. However, COVID-19 costs are a concern.
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Lamb Weston (LW) to Report Q4 Earnings: What Should You Expect?
by Zacks Equity Research
Lamb Weston's (LW) fourth-quarter fiscal 2021 performance is likely to reflect better shipment trends to customers served by the Foodservice unit. However, pandemic-induced costs are a concern.
Inter Parfums (IPAR) Raises 2021 View Again on Solid Q2 Sales
by Vrishali Bagree
Inter Parfums (IPAR) came up with robust sales numbers for the second quarter of 2021, reflecting brand strength. Also, management raises guidance for 2021.
Philip Morris (PM) Q2 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Philip Morris' (PM) second-quarter performance reflects gains from growth in revenues from combustible and RRPs categories as well as favorable pricing variance in several markets.
Here's Why Archer Daniels (ADM) is Poised for Q2 Earnings Beat
by Zacks Equity Research
Archer Daniels' (ADM) Q2 results are expected to reflect gains from strength in the Nutrition, and Ag Services and Oilseeds units as well as persistent demand.
Hain Celestial (HAIN) Aims to Boost Brands & Build Efficiency
by Zacks Equity Research
Hain Celestial's (HAIN) transformation strategy includes simplifying portfolio and building cost efficiency.